Blood p-tau217 testing in real-world practice enhances diagnostic accuracy and neurologists' diagnostic confidence, with the greatest diagnostic shifts seen in mild cognitive impairment and dementia.

Founded by former IT specialist Conor Butts, the company is now zeroing in on creating a more comfortable screening process for pediatric patients.

Neurocast.ai today announced that re.Mind has joined as an investor. The undisclosed investment will accelerate the company’s ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

If you thought your test-taking days ended when you left school, think again. Recent research shows that about 76% of organizations with more than 100 employees rely on assessment tools such as ...

By Dr. Liji Thomas, MD By merging voice instability, gait asymmetry, and tremor-driven handwriting changes into a single explainable AI framework, researchers show how digital biomarkers can move ...

BELFAST, Northern Ireland, Feb. 10, 2026 /CNW/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care ...

Demonstrate to clients the alignment between their risk tolerance and their investment portfolio with the clear and transparent risk profiling and scoring tools available within Direct Advisory Suite.

Psychology Today's online self-tests are intended for informational purposes only and are not diagnostic tools. Psychology Today does not capture or store personally identifiable information, and your ...

The intersection of sleep medicine and neurodegenerative diseases has emerged as an area of increasing scientific and clinical importance. Sleep disorders, ...